We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
320 result(s) found, displaying 1 to 10
-
Oct-2025Prescription medicine evaluationActive ingredient: Fremanezumab.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for FERRIC CARBOXYMALTOSE-TEVA iron (as ferric carboxymaltose) 1000 mg/20 mL solution for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for FERRIC CARBOXYMALTOSE-TEVA iron (as ferric carboxymaltose) 500 mg/10 mL solution for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for FERRIC CARBOXYMALTOSE-TEVA iron (as ferric carboxymaltose) 100 mg/2 mL solution for injection vial.
-
Prescription medicine registrationActive ingredients: ferric carboxymaltose.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for APIXABAN-TEVA apixaban 2.5 mg film-coated tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for APIXABAN-TEVA apixaban 5 mg film-coated tablet bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for APIXABAN-TEVA apixaban 2.5 mg film-coated tablet bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for APIXABAN-TEVA apixaban 5 mg film-coated tablet blister pack.
-
Cancellation by sponsorRequested by Teva Pharma Australia Pty Ltd